Eli Lilly (LLY) Asset Utilization Ratio (2010 - 2026)

Eli Lilly (LLY) posted Asset Utilization Ratio of 0.63 for Q1 2026, up 10.05% quarter-over-quarter from 0.57 in Q4 2025, and up 8.2% year-on-year from 0.58 in Q1 2025.

Eli Lilly (LLY) Asset Utilization Ratio (2010 - 2026) Analysis & Trends

Eli Lilly (LLY) has reported Asset Utilization Ratio for 18 consecutive years, with 0.63 the latest figure, recorded in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.63, up 8.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.63 (up 8.2% YoY), and the FY2025 annual result was 0.68, up 8.02% from the prior year.
  • Asset Utilization Ratio was 0.63 for Q1 2026 at Eli Lilly, up from 0.57 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.63 in Q1 2026 and troughed at 0.54 in Q1 2023.
  • Average Asset Utilization Ratio over 5 years is 0.58, with a median of 0.57 recorded in 2024.
  • Year-over-year, Asset Utilization Ratio grew 12.35% in 2022 and declined 11.94% in 2023.
  • Over 5 years, Asset Utilization Ratio stood at 0.59 in 2022, then slipped by 4.93% to 0.56 in 2023, then grew by 4.28% to 0.58 in 2024, then slipped by 1.8% to 0.57 in 2025, then advanced by 10.05% to 0.63 in 2026.
  • Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.63 in Q1 2026, 0.57 in Q4 2025, and 0.55 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 0.63
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 0.48
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 0.46
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 0.50
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 0.50
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 0.41
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.52
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 0.12
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 0.34

Historic Data

Download Data
DateValue
Mar 31, 2026 0.63
Dec 31, 2025 0.57
Sep 30, 2025 0.55
Jun 30, 2025 0.56
Mar 31, 2025 0.58
Dec 31, 2024 0.58
Sep 30, 2024 0.55
Jun 30, 2024 0.57
Mar 31, 2024 0.56
Dec 31, 2023 0.56
Sep 30, 2023 0.57
Jun 30, 2023 0.55
Mar 31, 2023 0.54
Dec 31, 2022 0.59
Sep 30, 2022 0.62
Jun 30, 2022 0.62
Mar 31, 2022 0.61
Dec 31, 2021 0.58
Sep 30, 2021 0.58
Jun 30, 2021 0.56